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                                       ABSTRACT 
INTRODUCTION: 
                   Myocardial infarction is a syndrome arising from injury to the 
myocardial tissues due to imbalance in the perfusion and demand with the major 
cause being  coronary atherosclerosis with a superimposed coronary thrombus. 
When a myocardial injury occurs, various enzymes are being released in to the 
blood after two hours and they are detectable in the blood by various assays. 
Troponins can detect very small degrees of myocardial damage. Troponin T has 
practical advantages over CK-MB   in the assessment of left ventricular ejection 
fraction. Its measurement directly correlates with the infarct size which is 
inversely proportional to the  ejection fraction. 
AIMS AND OBJECTIVES: 
      To identify left ventricular ejection fraction of less than or equal to 
40percent by quantitatie Troponin T measurement after first episode of ST 
elevation Myocardial Infarction.  
MATERIALS AND METHODS: 
        This study was conducted in Government Royapettah Hospital in the 
department of medicine between July and December 2012.Fifty consecutive 
patients with first attack of ST elevation of myocardial infarction were selected 
and observed.  Troponin T levels are measured 12 to 48 hours after admission 
so as to obtain its peak value. Two dimensional Echocardiography was done 3  
to 4 weeks later and ejection fraction was measured. The relationship between 
left ventricular ejection fraction and troponinT concentration was studied using 
spearman’s correlation coefficient.  
OBSERVATION AND RESULTS: 
         There was a strong negative correlation between the left ventricular 
ejection fraction and Troponin T levels. Spearman’s rank correlation coefficient 
was -0.874 with p values <0.0001. 
CONCLUSION: 
     Troponin T shows a strong negative correlation with left ventricular ejection 
after a first episode of myocardial infarction. Its measurement is a quick, cheap, 
sensitive and highly specific method in identifying cardiac injury and to 
determine low ejection fraction <40 percent which is associated with 
complications. 
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INTRODUCTION 
          Myocardial infarction is a syndrome arising from injury to the 
myocardial tissues due to imbalance in the perfusion and demand with the 
major cause being  coronary atherosclerosis with a superimposed 
coronary thrombus. When a myocardial injury occurs, various enzymes 
are being released in to the blood after two hours and they are detectable 
in the blood by various assays. Cardiac troponin T, troponin I,  creatine 
kinase MB(CK-MB) are all important biomarkers of myocardial injury  
and when elevated, signify myocardial damage with good sensitivity and 
specificity
[1,2]
.CK-MB has a lot of false positive values as they can be 
elevated in conditions associated with skeletal muscle injury. Troponin T 
and I are more specific than CK-MB for cardiac injury. CK-MB starts 
decreasing by 12 hours and at 24 hours, the sensitivity of Troponin is 
very high
[3]
. Troponins can detect very small degrees of myocardial 
damage. Troponin T has practical advantages over CK-MB in the 
assessment of left ventricular ejection fraction. Troponin T starts to rise 
by 3-12 hours and peaks at 12 hours from the onset of pain. However the 
plateau phase lasts up to 48 hours. Thus, there is a large time window for  
the peak value. So unlike CK-MB, multiple measurements are not needed 
in determining the peak value. Also its concentration is unaffected by 
thrombolysis after the first 12 hours. Thus its measurement directly 
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correlates with the infarct size which is inversely proportional to the  
ejection fraction. 
DEMOGAPHY: 
Every year 1.1 million people experience myocardial infarction in 
United States. Six million people were admitted for consideration of the 
disease and 46,000 people die of coronary artery related deaths. In UK, 
coronary artery disease is the most common cause of death. The average 
incidence of myocardial infarction in UK in the age group of 30 to 69 
years is 600 per one lakh in males and 200 per one lakh in females. India 
is the country where most people with cardiac diseases reside. India 
reported most number of deaths due to CAD in 2002 and it is expected to 
double by the year 2015. If proper initiative is not taken in time, India 
will be harbouring around 62 million people with heart diseases by 2015 
as compared to US which will be having only 16 million by then. The 
incidence of myocardial infarction in India among young is on the rise in 
the last three years. In western countries, CAD is considered as a disease 
of old. Only 23 percent of deaths occur blow the age of 70 yrs whereas in 
India, 52 percent of CAD deaths occur in the age group less than 70 
years. This leads to loss of productive years of working. In the year 2000, 
an estimated 9.2 million productive years were lost in our country with 
expected rise to about 17.9 million by the year 2030.[94]  The huge load 
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of patients with coronary artery disease in our subcontinent is probably 
due to the large population and due to the presence of cardiovascular risk 
factors in a large scale. 
The INTERHEART study which was conducted in around 52 
countries tell that the coronary risk factors like diabetes, hypertension, 
smoking, obesity, hyerlipidemia are more prevalent in India than any 
other countries. In 1990, there were 1.7 million deaths in India and it 
doubled by the year 2010. Studies tell that coronary artery disease 
manifests ten years earlier in India than any part of the world.   In rural 
India, the percentage of people with heart disease has increased from 1-2 
to 3-5 percent. In urban India, it has gone up from 2-3 to 10-11 percent. 
This increased prevalence in urban population is probably due to increase 
in stress, decreased physical activity, increased intake of high calorie 
diets and increased prevalence of risk factors. Studies among asian Indian 
people tell that almost half of the patients with myocardial infarction are 
in age group less than 50 years of age and 25 percent occur less than 40 
years of age.  
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REVIEW OF LITERATURE 
Atherosclerotic cardiovascular disease is the leading cause of death 
and disability in America. The chief risk factors  are LDL,HDL, TGL, 
cholesterol, blood pressure, smoking, BMI[4]. Coronary circulation is  
unique in the way that they are perfused in diastole rather than in systole. 
Systolic contraction redistributes perfusion from subendocardium to 
subepicardium of heart and impedes the coronary arterial inflow and at 
the same time increasing the coronary venous outflow. During diastole, 
coronary arterial inflow increases with perfusion to the subendocardial 
layer. At the same time, coronary outflow fall. 
Under normal resting conditions, the average coronary blood flow 
is 0.7 to 1.0 ml/min/gm and can raise up to four to five during 
vasodilation.[5].Coronary reserve is a phenomenon of ability  to raise the 
coronary blood flow in response to vasodilators. In conditions like 
tachycardia where the diastolic time available for subendocardial 
perfusion is decreased and in conditions of increased preload, the 
maximum perfusion and coronary reserve are reduced. Coronary reserve 
is also reduced in conditions like elevated systolic pressure, heart rate, 
contraction which are determinants of oxygen consumption or in 
conditions which decrease arterial oxygen supply like anemia and 
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hypoxia. Subendocardial flow occurs  mainly during diastole and starts to 
reduce when mean coronary pressure of 40 mmHg is reached.[6] 
Contrary to that, throught the cardiac cycle the subepicardial flow occurs 
and is maintained till the coronary pressure reaches 25mmHg. Increased 
oxygen consumption in subendocardium is the reason for that, which 
needs higher resting flow level[7].Thus subendocardial ischemia can be 
precipitated even in conditions where  coronaries are normal. Studies 
have shown that the coronary autoregulation is active till the mean 
coronary pressure reaches 40 mmHg.(DBP 30 mmHg)    
DETERMINANTS OF MYOCARDIAL OXYGEN 
CONSUMPTION: 
Consumption of oxygen is near maximal at rest in myocardium.[8] 
reaching approximately 75 percent of arterial content. Because of this 
property, increase in coronary flow and oxygen delivery caters to the 
need of myocardium. Apart from coronary flow, oxygen delivery is 
directly determined by arterial oxygen content. Anemia results in 
proportional decrease in oxygen delivery. The factors which determine of 
myocardial oxygen consumption are blood pressure, heart rate, 
myocardial wall stress and LV contractility. 
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MAINTENANCE OF CORONARY TONE: 
Normally, the epicardial arteries donot significantly contribute to 
the coronary vascular resistance. But their diameter is altered by a 
number of factors which are released from the platelets, certain 
neurohumoral agonists, neural tone and by local control . The substances 
that modulate are acetylcholine, nor epinephrine, bradykinin, histamine, 
substance p, endothelin, substances released by the platelets like 
thrombin, serotonin, adenosine-di-phosphate, thromboxane, vasodilators 
like adenosine, papaverine, dipyridamole and nitroglycerine.   These all 
act through certain endothelial dependant factors such as nitric oxide, 
Endothelial Dependent Hyperpolarising Factor (EDHF), prostacyclin, 
endothelin. 
NITRIC OXIDE:  
It is produced by the endothelium in the process of conversion of 
L-arginine to citrulline mediated by nitric oxide synthase. The nitric 
oxide binds to guanyl cyclase,thus increasing cGMP production and 
decreasing intracellular calcium thus producing vascular relaxation. 
Vasodilation mediated by nitric oxide is enhanced by changes in coronary 
shear stress. This vasodilation is impaired in many diseases and in 
patients with more than one risk factor for coronary artery disease .This is 
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by superoxide anion generated as a result of oxidative stress which 
inactivates the vasodilator nitric oxide. This is seen in conditions like 
atherosclerosis , hypertension, diabetes mellitus. 
Endothelial Derived Hyperpolarising Factor:  
Endothelial Derived Hyperpolarising Factor is supposed to be a 
metabolite of arachadonic acid metabolism and is produced by the 
endothelium. This substance hyperpolarises vascular smooth muscle and 
opens the calcium activated potassium channels thereby dilating arteries. 
It is through EDHF, agents like bradykinin as well as shear stress induced 
vasodilation acts. 
Prostacyclin:  
It is a product of metabolism of arachdonic acid through 
cyclooxygenase. It is a coronary vasodilator. Vasodilatory prostaglandins 
are very important determinant of collateral vessel tone rather than of 
native vessels and studies have proven that. 
Endothelin: 
ET1, ET2, ET3 are endothelium dependent constricting factors. 
ET1 is a potent constrictor and has prolonged action. The effects of 
endothelin are mediated through ET receptors. Endothelin is not involved 
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in regulating normal heart but it can alter the vascular tone in conditions 
like heart failure where its level rises.   
DETERMINANTS OF CORONARY VASCULAR RESISTANCE:  
Resistance to the flow of coronary blood has three major 
components. First is by the epicardial coronary artery. Under normal 
conditions, negligible resistance is noted in these vessels. The second 
component is due to the microcirculatory resistance arteries and arterioles 
within the myocardium. Third component is due to the contraction of 
heart and due to the systolic pressure development within the left 
ventricle. The compressive effects are prominent in the subendocardium. 
MYOGENIC REGULATION:  
Ability of the vascular smooth muscle to which opposes changes in 
coronary arteriolar diameter is called myogenic regulation. Thus vessels 
relax when the distending pressure is elevated. Myogenic tone is a 
property of vascular smooth muscles in animals and humans [9,10] . It 
depends on the vascular smooth muscle calcium entry. It brings back 
local coronary flow back to original level. It occurs chiefly in arterioles 
less than 100mm. 
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SYMPATHETIC INNERVATIONS: 
Under normal conditions, there is no resting sympathetic tone. 
During sympathetic activation, the tone of coronaries is moulated by  
norepinephrine which is released from the sympathetic nerve endings 
along with the circulating epinephrine and norepinephrine. Sympathetic 
stimulation leads to α1 mediated constriction and vasodilation mediated 
by β2 receptors. The final effect is to dilate the epicardial coronary 
arteries. When the coronary dilation mediated by nitric oxide is impaired, 
the vasoconstriction mediated by α1receptors predominate and can 
increase the severity of stenosis. Summarising, β1 increases the 
myocardial oxygen consumption.α1 mediates coronary constriction and β 
2 mediates coronary vasodilation. In normal conditions, β2 mediated 
dilation predominates. 
CORONARY VASOSPASM:  
It causes transient functional blockage of coronary artery. It is 
usually reversed by nitrates. In coronary artery disease, it is the 
endothelial disruption which plays an important role in causing focal 
vasospasm. Here, the normal vasodilation by the autocoids and the 
sympathetic stimulation is converted in to a vasoconstrictor response. 
This is due to the lack of endothelium dependent vasodilation. In 
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conditions like prinzmetal’s angina there is sensitization to 
vasoconstrictor mechanisms. A protein called Rho which binds GTP can 
sensitize the vascular smooth muscle to calcium by inhibiting myosin 
phosphatase activity through a protein called Rho kinase.  
Physiology of Right Coronary Blood Supply:  
There are differences in the right coronary supply to the RV free 
wall compared to the left ventricle. The arterial pressure which supplies 
the right coronary exceeds the right ventricular pressure. This decreases 
the compressive factors of coronary reserve. The right ventricular oxygen 
consumption is also lower than the left ventricle. The oxygen saturations 
of the right coronary veins are higher than in the left coronary circulation. 
CORONARIES-ANATOMY: 
Right and left coronaries arise from ascending aorta from its 
anterior and posterior sinuses. They usually arise above the cuspal 
margins. The main artery and the main branches are usually 
subepicardial. “Dominance” is the term used to refer to the coronary 
artery that gives rise to posterior interventricular branch. This artery 
supplies posterior part of ventricular septum and part of posterolateral 
wall of left ventricle. In most of the cases, left coronary is the dominant 
artery. The right and left coronaries anastamose abundantly during fetal 
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life but by the and of first year, they are reduced. The diameter of 
coronary arteries range from 1.5 to 5.5mm at the origin. Normally, the 
left coronary is larger than the right coronary. 
Right coronary artery:  
It arises from the anterior aortic sinus. It is usually single. It 
reaches the atrioventricular groove and runs vertically to the right cardiac 
border. It anastamoses with the circumflex branch of left coronary artery. 
The first branch is the Arteria Coni Arteriosi or the Conus artery. It is 
sometimes called the third coronary artery. It anastamoses with its 
counterpart from left side and forms annulus of vieusssens- an 
anastamotic circle around the pulmonary trunk. The other branches are 
atrial (anterior, lateral and posterior groups) , artery of sinuatrial node 
(sometimes from the circumflex branch of left coronary), septal branches 
(from posterior inter ventricular artery). The largest posterior septal artery 
usually supplies atrio ventricular node.    
Left coronary artery:  
It is larger than right coronary artery. Supplies almost whole of left 
ventricle and atrium. It arises from left posterior aortic sinus. Left 
coronary supplies most of interventricular septum. It has two or three 
main main branches- the notable ones are anterior interventricular artery 
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and circumflex artery. The anterior interventricular artery produces right 
and left anterior ventricular and anterior septal branches. The circumflex 
artery continues as posterior descending artery in some. In 90% of 
people, a large ventricular branch, the left marginal artery arises 
perpendicularly from circumflex artery and ramifies over the rounded 
obtuse margin. 
It is the coronary pressure distal to the stenosis which determines 
the maximum myocardial perfusion. Because of the property of 
autoregulation, the flow remains the same even if the stenosis increases in 
severity. Because of coronarary reserve, flow can increase 5 times than 
the resting flow values. Until the stenosis reaches 50%, the epicardial 
artery resistance increases very little. So there is no pressure drop across 
stenosis until stenosis exceeds 50%. As the severity of the stenosis 
increases, the pressure drop across stenosis occurs. This pressure drop 
decreases the distal coronary pressure which is the major determinant of 
perfusion to microcirculation. Above 70% of diameter reduction, even 
small increase in severity of stenosis causes large increase in stenosis 
pressure drop and decrease in distal coronary pressure and large decrease 
in maximum vasodilated perfusion of microcirculation. If the stenosis is 
more than 90 percent which is called as critical stenosis, vasodilation of 
the subepicardial vessels with drugs cause further decrease in distal 
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coronary pressure. This causes reduction in subendocardial flow leading 
on to transmural steal phenomenon.  
CONSEQUENCES OF ISCHEMIA: 
Sudden stoppage of flow following a coronary occlusion causes the 
aerobic metabolism to an end and depletes creatine phosphokinase. This 
directs the cellular metabolism towards anaerobic glycolysis, leading on 
to lactate accumulation and decrease in ATP levels. With continuing 
ischemia, acidosis develops and thereby causing potassium efflux in to 
extracellular space. Myocyte death follows as the levels of ATP fall 
below which is needed to maintain membrane function. 
The extent of injury after occlusion depends on residual blood flow 
in coronaries, the location of block, and the factors which determine the 
oxygen consumption. Injury starts within 20 minutes after the occlusion 
in the absence of collaterals.[11] Irreversible injury starts initially at 
subendocardial region and proceeds to subepicardial region. This 
suggests higher oxygen consumption in the subendocardial layer. In 
experimental cases, the entire subendocardium is injured irreversibly 
within one hour of occlusion. Prior repeated attacks of reversible 
ischemia or angina before an episode of occlusion can reduce the 
irreversible injury through preconditioning. [12] 
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Residual coronary flow which occurs through the occluded artery 
is the determinant of time taken for irreversible injury to occur. The size 
of the infarcted myocardium and area which is at risk of ischemia during 
the period of total occlusion depends on the collateral flow. When the 
subendocardial collateral flow is greater than 30 percent of resting flow 
values, occurrence of infarction is prevented for more than one hour. 
Subtotal occlusion can for atleast 5 hour without producing significant 
irreversible injury[13]. Cell death arises by two mechanisms. The first 
mechanism is by reperfusion injury where the reperfusion leads to 
necrosis of myocytes with disruption of sarcolemma causing leakage of 
the cellular contents. The injury is further increased by the influx of 
leucocytes to the injured area. The other mechanism of cell death is by 
apoptosis. 
Myocardial pre and post conditioning:  reversible ischemia 
occurring before a prolonged coronary occlusion produces necrosis of 
myocytes a term called acute preconditioning.[12,14] it delays the 
irreversible myocardial injury. Pharmacologic preconditioning is 
achieved by activation of adenosine A1 receptor activation, by drugs 
causing protein C or open K
+ 
ATPase activation. On a chronic basis also 
preconditioning can develop (delayed preconditioning) and, it can persist 
till 4 days if induced.[15]. Preconditioning protects the heart from 
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ischemia-induced stunning and reduces size of infarct. The mechanisms 
involved are synthesis of proteins, upregulation of the inducible form of 
NO synthase, cyclooxygenase, and mitochondrial K
+
-ATP channel 
opening. Myocardial postconditioning is a final protective mechanism. 
This protects the heart by producing ischemia intermittently or by 
administering drugs at the time of reperfusion. It has a capability to affect 
irreversible injury because it can be induced after myocardial ischemia is 
established rather than requiring pre-treatment.[12] 
DIAGNOSIS - Chest pain : 
The decision whether to admit the patient in coronary care setting , 
in observation ward, to discharge him home all depends upon careful 
history, physical examination, electrocardiogram, and in those suspected 
of ACS, biomarkers. The factors suggesting high likelihood of having 
ACS and risk of short term complications include prolonged or 
accelerating ischemic symptoms, evidence of congestive cardiac failure, 
ECG abnormalities that are not told to be old, and elevated markers of 
myocardial injury[16,17] 
History:  
A history of myocardial infarction is associated with high risk of 
obstructive coronary disease but also increased likelihood of multivessel 
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disease. Women with suspected ACS have less chances of epicardial 
coronary artery disease than men of same age and similar clinical 
presentation. If present, it is of less severity[18,19]. Beyond the age of 70 
years, risk of coronary artery disease and adverse outcome increases.[20] 
History regarding diabetes can help identify high risk patients among 
those with ACS.[21,22]. ACC/AHA guidelines suggests, the risk factor 
data should not be used to determine whether the patient should be 
admitted or not.[23] . Also the family history regarding coronary heart 
disease is not a useful indicator in the diagnosis or prognosis of the 
patients with chest pain.  
Physical examination: 
Initial examination should focus on the precipitating factors (e.g 
hypertension), comorbid conditions (eg COPD), evidence of 
complications like CCF, hypotension, new onset mitral regurgitation.[23]. 
Also a look in to the peripheral vessels for the presence of bruit, absence 
of pulses should be made which suggests extracardiac vascular disease. If 
the clinical presentation does not suggest it is of cardiac origin, the search 
for noncoronary cause should be made. It includes first the life 
threatening conditions like aortic dissection, pulmonary embolism and 
then in to other causes like pericarditis or esophageal discomfort. Aortic 
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dissection is suggested by disparities in blood pressure or pulses or a new 
murmur of aortic regurgitation accompanied by back or midline anterior 
chest pain.  Pulmonary embolism manifests as tachycardia, tachypnea, 
and a loud component of second heart sound. Pneumothorax manifests 
with differences in breath sounds and dyspnea.  
Electrocardiogram: 
An electrocardiogram provides valuable information regarding the 
diagnosis and prognosis. [16, 17]. New onset persistent or transient ST 
segment abnormalities (>0.05mV) which develop during an episode and 
resolve after the symptoms resolve strongly suggests acute ischemia and 
severe coronary disease. Any lesser amount of ST segment deviation or T 
wave inversion of less than or equal to 0.3 mV are called non specific 
changes. A completely normal ECG does not rule out the possibility of 
acute coronary syndrome.  One to six percent of such patients evolve in to 
acute MI and up to 15 percent have unstable angina. Yet these patients 
have better prognosis than those who presented with ECG 
changes.[17,24]. A prior ECG improves the diagnosis acute myocardial 
infarction if combined with serial measurement of biomarkers.[25] 
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Fig:1 Categorization  of patients according to  major cardiac events 
within 72 hours of admission[28]. 
History, physical examination, 12 led ECG, cardiac markers all 
help in assigning patients to four categories- non cardiac chest pain, 
chronic stable angina, possible ACS, definite ACS[23] patients with ST 
elevation are triaged immediately for reperfusion therapy. Patients with 
ST and T wave changes ,ongoing chest pain, positive cardiac markers or 
with hemodynamic abnormalities should be admitted in hospital for 
management of ischemia. For patients with possible or definite ACS who 
do not have definite ECGs or whose cardiac markers are normal initially 
are advised admission in a chest pain unit. Patients with low risk can be 
observed for 4 to 8 hours while undergoing ECG monitoring and serial 
measurement of cardiac markers. Patients who develop signs of ischemia 
are admitted to the coronary care unit ( fig:1) 
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Early noninvasive testing: 
The low risk patients should be subjected to stress testing to know 
their performance status.  Treadmill exercise electrocardiography is an 
inexpensive test that is available in any centers. They provide reliable 
prognostic information of low risk patients. Bruce or modified Bruce 
protocol is used. One study found that the patients with low risk who had 
negative stress test had less recurrence of events than those with positive 
or equivocal test at the end of 6 months[26]. Bruce or modified Bruce 
treadmill protocol is used for exercise testing. Studies have shown that 
patients who have low clinical risk of complications can safely undergo 
exercise testing within 6 to 12 hours after presentation to hospital.[27] 
Immediate stress testing should not be done for patients with 
electrocardigraphic findings consistent with ischemia not known to be 
old, ongoing chest pain or evidence of congestive cardiac failure. 
The indications for exercise stress testing are the following-  
1. Two sets of cardiac enzymes at 4 hourly intervals should be 
 normal. 
2. ECG at the time of presentation and pre exercise 12 lead ECG 
shows no significant abnormality. 
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3. Absence of rest abnormalities, 
4. Lessening chest pain symptoms or persistent atypical symptoms,  
5. Absence of ischemic chest pain at the time of exercise testing.  
The contraindications for stress testing are 
 1. New or evolving ECG abnormalities on rest tracing,  
2. Abnormal cardiac enzymes, inability to perform exercise,  
3. Worsening symptoms, 
4. Indications for coronary angiography is likely. 
Imaging tests:  
Stress ECHO cardiogram or radionucleotide scans are the preferred 
non invasive testing modalities for people who cannot undergo treadmill 
electrocardiographic testing because of disability. They are less readily 
available and more expensive than exercise electrocardiography. But are 
more sensitive in detecting coronary artery disease and localize and 
quantify the extent of jeopardised myocardium. High risk scans are 
associated with increased risk of major cardiac events than those with low 
risk scans.[29,30]. The radionucleotide scans also help to detect whether 
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the patients symptoms are due to ischemia. Their availability scans did 
not influence the management, but rather reduced the admission 
rates.[31] 
Echocardiography can be used with or without stress to detect wall 
motion abnormalities which denotes myocardial ischemia.[32,33]. The 
presence of regional wall motion abnormalities, correlates with worse 
prognosis. Even with all these benefits, guidelines recommend exercise 
echocardiography as the preferred first-line test. 
Multidetector Computerized Tomography (MDCT) has  been 
evaluated  in identifying the patients with risk for ACS. Cardiac magnetic 
resonance imaging is also being used in assessing the patients with 
suspected ACS[53]. In a study that used cardiac MRI to quantify 
myocardial perfusion, ventricular perfusion and hyper-enhancement in 
patient with chest pain, the sensitivity  for ACS was 84% and the 
specificity was 85%. T2- weighted image adds on to the diagnosis and 
helps in differentiating acute from chronic perfusion defects. Stress MRI 
with adenosine and MRI coronary angiography are being studied. 
Additional studies and newer techniques are necessary to reduce radiation 
exposure from such testing before they are adopted widely. 
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ST ELEVATION MYOCARDIAL INFARCTION: 
Myocardial infarction refers to myocyte cell death caused due to 
prolonged ischemia. Characteristic pathologic findings include 
coagulation necrosis and contraction band necrosis with patchy areas of 
myocytolysis at the periphery of the infarct.  During acute phase, 
myocyte loss in the infarct zone is due to coagulative necrosis which then 
proceeds on to inflammatiom, phagocytosis of necrotic myocytes and 
repair leading on to scar formation. Clinical diagnosis requires history 
along with evidence of myocardial necrosis using biochemical, 
electrocardiographic and imaging modalities.  The sensitivity and 
specificity of the tools vary depending on the time after the onset of 
infarction. 
Revised definition classifies MI in to five types depending on the 
circumstances on which it occurs[34]  
1. Spontaneous; this is related to ischemia caused by plaque 
erosion and/ or rupture, fissuring or dissection. 
2. Secondary to ischemia caused by demand-supply mismatch ( 
coronary spasm, embolism, arrhythmias, anaemia, 
hypertension, hypotension) 
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3. Sudden unexpected cardiac death, including cardiac arrest, 
with symptoms suggestive of myocardial ischemia, and 
presumably accompanied by new LBBB, or new ST- 
segment elevation, or a new major obstruction in a coronary 
artery angiographically and/or pathology, but death 
occurring before blood samples are taken, or before the 
cardiac biomarkers appear in blood. 
4a. Myocardial infarction associated with primary coronary 
intervention (PCI) 
4b. Myocardial infarction associated with stent thrombosis. 
5. Myocardial infarction associated with CABG. 
Criteria for acute ,Evolving or Recent MI[35] 
Any one of the criteria given below fulfils the diagnosis of acute, 
evolving, or recent myocardial infarction: 
1. Rise and fall of biochemical markers of myocardial injury 
with atleast one of the following: 
a. symptoms of ischemia 
b. pathologic Q wave formation in the ECG 
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c. Changes in the electrocardiogram consistent with 
ischemia (ST segment elevation or depression) 
d. New loss of viable myocardium or new regional wall 
motion abnormality evidenced by imaging methods. 
2. Evidence of acute myocardial infarction documented 
pathologically. 
Criteria for Healing or Healed Myocardial Infarction 
Any one of the following criteria needs to be fulfilled for the 
diagnosis of healing or healed myocardial infarction. 
1. New pathologic Q waves in serial ECGs. The patient may or 
may not remember previous symptoms. Cardiac injury 
markers of may have normalised.  
2. Healed or healing infarction by pathological examination  
Incidence:  
STEMI is a major health problem in developed nations and its 
impact is raising in the developing nations.[36]  In United States, almost 
one million people suffer from acute MI and more people enter coronary 
care units. The rate rises for both men and women with increasing age 
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with blacks being more affected than the whites(fig:2). The burden of MI 
in developing countries approach those of developed countries. Main 
concern in the developing nations is the limitations in the available 
resources to treat MI. This mandates major effors to be undertaken at 
international level to strengthen primary prevention programmes[37] 
 
Fig 2: Annual rates of first episode of MI by age, sex and race    
(data, Atherosclerosis Risk in Communities [ARIC] surveillance, 
1987-2004). 
 
       Mortality from STEMI has declined steadily. This is due in part to 
the reduction in the incidence of STEMI and secondly due to decrease in 
case fatality rate once STEMI has occurred. [39]. Coronary care has 
crossed several phases in managing patients thereby reducing the 
mortality.  The modern era-  “the reperfusion era” consists of initially 
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intracoronary followed by intravenous fibrinolysis, increased use of 
aspirin, and the development of primary percutaneous coronary 
intervention. Also patients’ care has also moved in to an evidence based 
coronary therapy and is influenced by guidelines and performance 
measures.[40-42] 
The immediate mortality rate of STEMI patients who are treated 
with aggressive reperfusion therapy is in the range of 6.5 to 7.5 
percent[43] but studies show that the mortality is 15 to 20 percent. This is 
due to the fact that about 30 percent of those who develop STEMI and are 
eligible to receive reperfusion therapy do not receiving the life saving 
treatment.[44]. This is in part may also due to the selection bias.  
Advanced age is one of the important determinants of mortality in 
patients with STEMI. Evidence suggests that reductions in the mortality 
in old patients with STEMI depends upon the strategies used during the 
first 24 hours where appropriate use of lifesaving reperfusion therapy has 
greater importance emphasizing  the need to extend the advances in 
therapy for STEMI to old patients[43] . Variation exists in the 
management and outcomes of patients with STEMI. Mortality rates are 
lower in hospitals with high rate of invasive procedures. Also mortality 
rates are higher in STEMI patients not cared for by cardiovascular 
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specialists[45]. Variation also occurs in the treatment of certain 
subgroups with STEMI especially women and blacks.  Evidence exists 
that much of the regional variation in outcomes derives from the 
characteristics of the patient and treatments received as opposed to the 
location where those treatments were delivered. 
Causes of myocardial infarction other than atherosclerosis[46] 
Arteritis: 
Luetic, granulomatous, Polyarteritis nodosa, Kawasaki disease, 
disseminated lupus erythematosis, Rheumatoid spondylytis, Ankylosing 
spondylitis,  
Traumatic: 
Laceration, thrombotic, radiation, 
Metabolic disease: 
Hurlers disease, homocystinuria, fabry’s disease, amyloidosis, 
juvenile intimal stenosis, psedoxanthoma elasticum,  
Coronary fibrosis secondary to radiation, intimal hyperplasia 
secondary to steroid use 
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Luminal narrowing by other mechanisms 
Prinzmetal angina, coronary spasm after nitroglycerine withdrawl, 
aortic or coronary dissection.  
Emboli to coronaries: 
Infective endocarditis, Non bacterial thrombotic endocarditis, 
prolapse of mitral valve, prosthetic valve emboli, cardiac myxoma, 
cardiopulmonary bypass, angiography, thrombi from intra cardiac 
catheters and guidewires, paradoxic emboli 
Congenital coronary artery anomalies: 
Coronary artery from pulmonary trunk left coronary from anterior 
sinus of valsalva, coronary arteriovenous malformation, coronary 
aneurysm.  
Myocardial oxygen demand supply disproportion: 
Aortic stenosis, aortic insufficieny, carbon monoxide poisoning, 
thyrotoxicosis, prolonged hypotension, Takosubo cardiomyopathy. 
Hematologic: 
Thrombocytosis, Polycythemia vera, disseminated intravascular 
coagulation, hypercoagulability, thrombosis, thrombocytopenic purpura 
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 Miscellaneous: 
Cocaine abuse, coronary contusion, catheterization 
Previously, the patients with MI were divided in to Q wave and 
non Q wave infarctions depending upon their ECG evolution over several 
days. The Q wave infarctions refer to transmural infarction whereas non 
Q wave infarctions refer to subendocardial infarctions. Studies indicate 
that the development of Q waves depend more on the size of infarct 
rather than the depth of the infarct.[47,48]. Now the term acute coronary 
syndrome is coined for these to avoid confusion taking in to account the 
pathophysiologic mechanisms involved and it seems to be more 
appropriate than the older terms. 
 
 
 
 
 
 
 
Fig3:(Flow chart depicting differentiation of patients with acute 
coronary syndrome in to various subtypes.) 
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Plaque:  
During the evolution of lipid laden plaques, transition can occur in 
the form of plaque disruption[49,50]. Plaque disruption exposes 
substances that promote platelet activation and aggregation leading on to 
thrombin formation and ultimately thrombus formation. The thrombus 
thus formed leads on to oxygen supply and demand imbalance and if 
severe can lead on to myocardial necrosis. 
Composition of plaque:  
The plaques which cause total occlusion of the coronaries are more 
complex and irregular than those which don’t cause STEMI. Histology of 
these plaque shows plaque rupture or erosion.  The thrombus composition 
can vary; white thrombi consisting of platelets, fibrin, or both and the red 
thrombi containing erythrocytes, fibrin, platelets and leucocytes.  The 
plaques which are prone for disruption overexpress enzymes that degrade 
the extracellular matrix of the plaque[51,52]. The intra-luminal pressure 
induced stress, coronary vasomotor tone, disruption of nutrient vessels 
and tachycardia combine to produce plaque disruption at the shoulder of 
the plaque. Number of physiological variables such as blood pressure, 
heart rate, blood viscosity, t-PA activity, PAI-1 levels, cortisol and 
epinephrine show a circadian rhythm and seasonal variation and increase 
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at the time of stress. This is the reason for STEMI occurring in the early 
hours of morning especially in winter and after natural disasters[53] 
Acute coronary syndromes:  
Plaque disruption exposes the thrombogenic substance that 
produces thrombus. In the absence of collaterals, completely occluded 
thrombi produce transmural injury of ventricular wall leading on to ST 
elevation in ECG. Infarction alters the depolarisation which is reflected as 
changes in QRS complex. The formation of Q waves is more 
characteristic of patients with STEMI and hence designated as Q wave 
myocardial infarction[54]. In a small subset of patients, diminution of R 
waves or notching of QRS is seen. Patients without ST segment elevation 
are termed as having unstable angina or NSTEMI. The patients with 
STEMI are candidates for reperfusion therapy either pharmacologic or 
catheter based. All patients with acute coronary syndrome should receive 
anticoagulant therapy and anti platelet therapy regardless of the type. 
GROSS PATHOLOGY: 
Coagulation necrosis:  
It is due to severe persistent ischemia. The central region of infarct 
shows features of coagulative necrosis. Muscle cells are arrested in the 
relaxed state. Stretching of myofibrils, with nuclear pyknosis, vascular 
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congestion, healing by phagocytosis are seen. Mitochondrial damage is 
present but without calcifications. 
Necrosis with contraction bands:  
It is also called as contraction band necrosis or coagulative 
myocytolysis. Ischemia followed by reflow may cause this type of 
necrosis [35]. Mitochondrial injury is present with calcification. It is 
caused due to the entry of calcium in to the dying cells causing arrest of 
cells in the contracted state. This occurs in the periphery of large infarcts 
and is associated more with the nontransmural than the transmural 
infarctions. 
Myocytolysis:  
Ischemia without necrosis if severe and prolonged can cause 
myocyte vacuolization termed as myocytolysis. 
Electron microscopy:  
Within 20 minutes of complete occlusion of coronaries, glycogen 
granules reduce in number and size, intra cellular edema develops and 
transverse tubular system and mitochondria become distorted.  These are 
reversible. After 60 minutes of occlusion, several changes occur in the 
myocyte in the form of swelling, disruption of mitochondria, margination 
of nuclear chromatin, amorphous aggregation, and relaxation of 
myofibrils. 
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Apoptosis:  
Otherwise called as programmed cell death, apoptosis is an 
additional pathway of myocyte death. The myocytes show shrinkage of 
cell, fragmentation of DNA and phagocytosis without infiltrates. Major 
impact of apoptosis appears to be on late myocyte loss and ventricular 
remodelling after MI. 
Modification of pathologic changes by reperfusion:  
If reperfusion occurs earlier,(within 15 to 20 minutes) necrosis can 
be prevented.(fig:4) Beyond this period, the number of salvaged 
myocytes relates directly to the length of the coronary occlusion. 
Reperfused infarcts show mixture of necrosis, haemorrhage, coagulative 
necrosis with contraction bands and distorted architecture of the cells. In 
reperfusion, early peaking of substances like CKMB and cardiac specific 
troponin T and I are seen. This is due to the accelerated washout of 
intracellular proteins. 
 
Fig:4  (consequences  of  occlusion  of  coronaries  and  the  effects  of 
reperfusion) 
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Right Ventricularmyocardial Infarction (RVMI):  
In about half of the patients with inferior wall infarction, some 
involvement of the right ventricular wall is seen.[41]It occurs in those 
with transmural infarction of inferoposterior wall and posterior portion of 
the septum. RVMI is usually associated with infarction of the adjacent 
septum and inferior left ventricular walls.  In about 3 to 5 percent of 
cases, isolated involvement of right ventricle is seen. The right ventricle 
has the ability to withstand long periods of ischemia and to recover its 
contractile function after it is being reperfused.[57]  
Atrial infarction: 
It is seen in about 10 percent of patients with STEMI. It often 
occurs with the ventricular infarction. And can cause atrial wall rupture. 
More commonly seen on the right side than the left side, this type of 
infarctions more frequently involve the atrial appendages. They are 
frequently accompanied by atrial arrhythmias[44] 
Abnormality in circulatory regulation is seen in patients with 
STEMI. It all begins with the anatomic or functional obstruction resulting 
in myocardial ischemia and if persistent, leading on to infarction and can 
depress in the left ventricular function leading on to fall in stroke volume 
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and rise in filling pressure. This decreases the aortic pressure and reduces 
the coronary perfusion pressure thereby producing a vicious cycle. 
 
(Fig:5  showing the events following an episode of  myocardial 
infarction) 
Dilation of the ventricle:  
Ventricular remodelling is also caused by dilation of the viable 
portion of the ventricle although infarct expansion plays an important 
role. It starts immediately after an episode of STEMI and progresses 
months or years thereafter. It is a compensatory mechanism through 
which the heart maintains the stroke volume. In due course of time, 
compensatory hypertrophy can occur. This is the reason for 
hemodynamic improvement in patients with STEMI after months.  
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Effects of treatment:  
      Ventricular remodelling is affected by factors like infarct size, scar 
formation after infarct, Reperfusion and other measures restrict the extent 
of myocardial necrosis and thus increase the stroke volume after MI. 
glucocorticoids and NSAIDS can cause scar thinning and increase in the 
infarct size. Blockers of RAAS attenuate the ventricular enlargement, 
decrease the endothelial dysfunction and has got antiatherogenic effects. 
Aldosterone blockade reduces the collagen deposition and decrease the 
development of ventricular arrhythmias.[57] 
Clinical features:  
Patients with STEMI appear anxious. An anguished facial 
expression is seen which is not usually seen in patients with angina.  
Some may be restless and move about in an attempt to find a comfortable 
position.  They often clutch or massage their chests and describe their 
pain with clenched fist against the sternum(the Levine sign). Patients in 
left ventricular failure and sympathetic stimulation, cold perspiration and 
skin pallor may be seen. They sit or propped up in bed gasping for breath. 
They may cough out frothy, pink, or blood streaked sputum. Depending 
on the cerebral perfusion, the patient may speak normally or may have 
confusion or disorientation.  
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Heart rate:  
It can vary from marked bradycardia to rapid regular or irregular 
tachycardia. Mostly thee pulse is rapid and regular in the range of 100 to 
110 beats per minute which slows down as the patient’s pain and anxiety 
are relieved 
Blood pressure:  
Most of the STEMI patients are normotensive although a reduced 
stroke volume is present. Previous normotensives show a rise in blood 
pressure especially in the early hours after infarction with values as high 
as 160/90 mmHg. This is probably due to the increased adrenergic drive 
secondary to pain, anxiety, and agitation. Previous hypertensives often 
become normotensives without treatment. In patients with massive 
infarction, there is acute fall of arterial blood pressure mainly because of 
the LV dysfunction and venous pooling secondary to administration of 
morphine and/or nitrates.  
Patients with systolic blood pressure less than 90 mmHg with 
evidence of end-organ hypoperfusion  are said to have cardiogenic shock.  
Presence of hypotension alone does not signify cardiogenic shock as 
some patients with inferior wall myocardial infarction have decreased 
blood pressure due to activation of Bezold-Jarisch reflex. This 
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hypotension resolves spontaneously or is accelerated by intravenous 
atropine (0.5 to 1 mg) or by the assumption of trendelenburg position. 
Some who are initially slightly hypotensive may gradually worsen with 
progressive reduction of the cardiac output due to increasing ischemia or 
extension of the infarction. Initially, more than 50 percent of the patients 
with inferior STEMI have evidence of excess parasympathetic activity 
with hypotension, bradycardia or both. In contrast to that, those with 
anterior STEMI show features of sympathetic excess with hypertension, 
tachycardia or both. 
Temperature and respiration:  
Most of the patients with STEMI develop fever as a response to 
tissue necrosis within 24 to 48 hours of onset of infarction. Temperature 
starts rising by 4 to 8 hours after the onset of infarction. It usually 
resolves by 4
th
 or 5
th
 day after infarction. The respiratory rate may be 
slightly elevated after the development of infarction. This is mainly due 
to the anxiety and pain and it reduces with treatment. In patients with 
pulmonary edema, the respiratory rate may be as high as 40 per minute. 
In older patients with cardiogenic shock or heart failure, Cheyne-Stokes 
respiration may be seen particularly after opiate therapy or in the 
presence of cerebrovascular disease 
 39 
JVP:   
The ‘a’ wave can be prominent in those with pulmonary 
hypertension secondary to LV failure. In patients with right ventricular 
infarction, the jugular venous distension can be seen with tall c-v waves 
of tricuspid regurgitation if there is associated necrosis of papillary 
muscles. In patients with STEMI who have hypotension, signs of 
hypoperfusion and flat neck veins, the depressed LV performance is in 
part to hypovolemia. The differentiation is made by using 
echocardiogram, or by using pulmonary artery floatation catheter. 
Carotids:  
A small carotid pulse suggests a reduced stroke volume whereas a 
brief upstroke is often seen in patients with mitral regurgitation or 
ruptured ventricular wall with a left to right shunt. The presence of pulsus 
alternans denotes severe dysfunction. 
Chest:  
Patients who develop LV failure present with moist rales. Diffuse 
wheezing can present in those with severe LV failure. Cough with 
hemoptysis can occur because of pulmonary embolism. Killip and 
Kimball proposed in 1967 proposed a prognostic classification scheme on 
the basis of severity of rales detected in patients with STEMI.  
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Killips prognostic classification in patients with STEMI: 
Class I : No rales; no third heart sound 
Class II : Presence of rales but to a mild to moderate degree  
   (<50% of lung fields); third heart sound may or may 
   not be present 
Class III : Presence of rales more than half of lung field and  
   frequently have pulmonary edema. 
Class IV : Presence of cardiogenic shock.     
CARDIAC EXAMINATION: 
Palpation: Usually the palpation of the precordium may yield 
normal findings. There may be presence of third or fourth heart sound. 
Auscultation:  The heart sounds, particularly the first heart sound 
is muffled and inaudible immediately after the infarct. And their intensity 
frequently increases in convalescence. A soft first heart sound may also 
reflect prolongation of PR interval. Patients with marked ventricular 
dysfunction and/or left bundle branch block may have paradoxical split of 
second heart sound. A fourth heart sound is almost universally present in 
patients in sinus rhythm with STEMI. However it is audible in most 
patients with chronic ischemic heart disease. 
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A third heart sound in patients with STEMI reflects severe LV 
dysfunction. It is caused due to the rapid deceleration of transmitral blood 
flow during protodiastolic filling of the left ventricle. This is best heard at 
the apex with the patient in left lateral position. A third heart sound is 
also heard due to the sudden inflow in to the left ventricle as in conditions 
like mitral regurgitation or ventricular septal defect which complicates 
STEMI.S3 and S4 from left ventricle are best heard at the apex whereas 
those arising from the right ventricle are best heard in the left sternal 
border and increase with inspiration. 
Murmurs: Systolic murmurs are commonly audible in patients 
with STEMI due to mitral regurgitation secondary to the dysfunction of 
mitral valve apparatus. An apical holosystolic murmur with a prominent 
thrill may arise due to the rupture of head of papillary muscle. In the case 
of interventricular septal rupture, the holosystolic murmur is heard along 
the left sternal border. The systolic murmur of tricuspid regurgitation is 
also heard along the left sterna border and it increases in intensity with 
inspiration. Tricuspid regurgitation is due to right ventricular infarction, 
or by infarction of right ventricular papillary muscle. It is also 
accompanied by prominent c-v wave in jugular venous pulse and RVS4. 
Frictional rubs: They are seen in patients with a large transmural 
infarcts.[58] They are commonly noted in the second or third day. They 
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are heard commonly along the left sterna border or just medial to the 
apex. The patients with frictional rub may have pericardial effusion on 
echocardiography. Delayed onset frictional rub with signs of pericarditis 
are seen in post myocardial infarction syndrome or the Dressler’s 
syndrome which is rare nowadays. Sometimes only the systolic portion of 
the rub is heard mimicking a systolic murmur of ventricular septal rupture 
or of mitral regurgitation. 
LABORATORY INVESTIGATIONS: 
The availability of cardiac biomarkers has helped the clinicians to 
diagnose MI in one third of the patients who did not fulfil the criteria for 
MI in the past. [59] it is important for the clinicians not to rely on the 
biomarker assays to initiate the specific treatment for STEMI patient. A 
12 lead ECG should serve to initiate such strategies. Cardiac enzymes are 
proteins released into the blood stream after the death of cardiac muscles. 
Myocardial necrosis compromises the integrity of the sarcolemmal 
membrane and as a result of which there is leak of intracellular 
macromolecules (cardiac biomarkers) in to the interstitium and then in to 
the lymphatics which is around the area of infarct. The rate of appearance 
of these biomarkers in blood depend on several factors like molecular 
weight, intracellular location, local blood and lymphatic flow and rate of 
elimination from the blood[60,61]  (see fig below)
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(Fig6: showing various cardiac biomarkers and their rates of rise and 
fall) 
 
(Fig7: showing the rate of appearance and disappearance of various 
cardiac biomarkers) 
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CREATININE PHOSPHOKINASE:  
Three isoenzymes exist (MM, BB, MB). BB subtype is seen in 
brain and kidneys. The skeletal muscle contains the MM subtype and the 
cardiac muscles contain both MM and MB subtypes. The MB isoenzyme 
is also present in small quantities in the intestine, tongue, diaphragm, 
uterus and prostate. Strenuous exercise is associated with rise in both the 
than the CK-MB and the total creatinine kinase.[62].  For practical 
purposes, the elevation of CK-MB may be considered due to myocardial 
infarction unless proved otherwise. CK-MB is analysed by specific 
enzyme immunoassays which use monoclonal antibodies against CK-
MB. [63] it is important to evaluate the temporal rise and fall of serial 
values rather than relying on a single value. At present, cardiac specific 
troponins play an important role in diagnosing myocardial infarction 
because of its specificity towards the cardiac muscle[64]. In addition to 
STEMI other forms of injury to cardiac muscle in the form of 
myocarditis, trauma, cardiac catheterization, shock and cardiac surgery 
can also cause rise in CK-MB values. Creatine phospho kinase starts 
rising 6 to 8 hours following injury and attains its peak in 24 hours and 
then decreases and reaches normal values in 3 to 4 days.  CPK levels are 
also markedly increased in conditions like muscular dystrophy, 
inflammatory muscle diseases, alcohol intoxication with or without 
delirium tremens, diabetes mellitus with or without ketoacidosis, 
convulsions, psychosis. Sensitivity and specificity of CPK is not as high 
as Troponins. 
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TROPONINS:  
The Troponin consists of three subunits. These consists of troponin 
C, troponin I, and troponin C. the troponin C binds Ca
2+
, troponin I which 
binds actin, and  troponin T which binds to topomyosin.  Majoriy of 
cardiac troponin T is in the troponin complex. Minor amount is in the 
cytosolic pool (6%). 2 to 5% of troponin I is in the cytosolic pool. 
Cardiac troponin T is a 33,000 dalton protein. When a infarction occurs, 
initially the troponin is released from the cytosolic pool followed later  
from the structural pool.[34] Different genes code troponin T and 
troponin I. Evidence tells that troponin complexes degrade in to various 
fragments and this may form the basis of getting insight in to the 
pathophysiologic events involved( ischemia or reperfusion) in the near 
future. troponin T starts rising 3 to 6 hours after the onset peaks at 24 to 
48 hours and then returns to baseline in 7 to 14 days. This persistence 
helps in late diagnosis of MI. Patients with STEMI who undergo 
thrombolysis and successful recanalization  have rapid release of cardiac 
Troponins and hence denote reperfusion.[66]  At the initial presentation, 
troponin levels may be normal. So it is necessary to repeat  the troponin 
levels at regular intervals. Studies tell that the risk of death from acute 
coronary syndromre is directly proportional to the cardiac troponin level. 
Patients with no detectable troponins have a good short term prognosis. 
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Elevated levels are also associated with conditions like congestive cardiac 
failure, sepsis, acute pulmonary embolism, chronic kidney disease, 
myocarditis and aortic dissection.  
SGOT:  
In a typical patient with acute myocardial infarction, the SGOT activity 
goes more than the the normal range within 8 to 12 hours following onset 
of chest pain. It then reaches a peak within 8 days and then returning to 
normal levels one month following the initial insult.  Other causes of 
sustained elevated SGOT levels are hepatic congestion, primary liver 
diseases, skeletal muscle disorders, shock. Myocarditis may also cause 
elevated levels of SGOT and it parallels the activity of the disease. if 
elevated in pericarditis, it may be due to subepicardial injury[65]. Around 
11 percent of female patients taking oral contraceptives can have elevated 
SGOT levels. SGOT may also raise following cardiac catheterization. 
   Activity of many enzymes including aldolase,malic 
dehydrogenase, isomerase, and ICD (Iso Citrate Dehydrogenase)  may 
increase following myocardial infarction.[67] Serum GGT, a lysosomal 
enzyme, exhibits increased activity late, reaching a peak within 8 days 
and returning to normal approximately 1 month following the initial 
insult. 
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Recommendations for Cardiac Enzyme Measurement: 
Cardiac enzymes are measured in anyone with suspected 
myocardial injury. From the cost- effective perspective, it is not necessary 
to measure both the troponins and CPK. Diagnosis of MI is made with 
elevations of troponin t, troponin I or CPK-MB. Or with serial 
measurements every 8 to 12 hours if the initial value is within normal 
limits. Retrospective diagnosis of myocardial infarction in the presence of 
skeletal muscle injury is more readily made with cardiac troponin 
measurement. Assays for the cardiac-specific troponins should supersede 
assays for CK-MB, not only for the diagnosis of MI but also for the 
assessment of reperfusion, reinfarction, and estimation of infarct size.[67] 
Other laboratory investigations:  
 
Serum lipids:  
During the first 24 to 48 hours of admission, total cholesterol and 
serum HDL levels remain near the baseline and and after that there is a 
precipitous fall of these levels. The fall in HDL cholesterol is more than 
that of total cholesterol and hence the HDL cholesterol ratio is not useful 
in the risk assessment. It is mandatory to obtain lipid profile in all patients 
admitted with STEMI within 24 to 48 hours of symptoms. Studies tell 
that hypolipidemic therapy improves the endothelial function and  
inhibits thrombus formation. This forms the basis of instituting early 
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hypolipidemic therapy in patients who are admitted with STEMI.[68]. 
For those who are admitted beyond 24 to 48 hours, accurate measurement 
of lipids is made only after 8 weeks after the infarction 
Hematologic findings:   
Elevation of white blood count start developing within 2 hours of 
chest pain and peaks in 2 to 4 days after infarction. The levels can range 
from 12,000 to 15,000. Sometimes even higher. There is propensity of 
differential count to shift towards the band forms. 
   The ESR is normal during the first two days and after that it rises 
reaching a peak on fourth or fifth day and may be elevated for weeks. 
There is also elevated hematocrit and CRP levels. Presenting 
haemoglobin values also predicts major cardiovascular events.[69] 
Cardiovascular mortality increases at values less than 14 to 15 mg/dl and 
more than 17 mg/dl. Former is due to anemia resulting in diminished 
tissue delivery of oxygen and latter is due to the increased blood 
viscosity. 
Electrocardiography :  
Electrocardiogram forms one of the corners tone in the diagnosis of 
STEMI. Many factors limit the ability of the ECG in localisation such as 
extent of myocardial injury, age of infarct, location, presence of 
conduction defects, presence of previous infarcts or pericarditis, 
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electrolyte disturbances. Changes in ST segment and T waves can be 
present in a number of conditions like pericarditis, stable and unstable 
angina pectoris, ventricular hypertrophy, early repolarisation, electrolyte 
imbalance, shock. Serial ECG help in differentiating these conditions. 
ECG also helps in localizing the site of occlusion. In addition to the 
diagnostic and prognostic use, ECGs also provide valuable information 
regarding the success of reperfusion after STEMI.[70] most patients bear 
the ECG changes for rest of their lives. But in a few, the ECG changes 
can even return to normal after many years. Many conditions produe 
ECG changes similar to infarction. Such ‘pseudoinfarction’ patterns are 
seen in ventricular hypertrophy, conduction disturbances, preexcitation, 
primary myocardial disease, pneumothorax, pulmonary embolism, 
amyloidosis, tumors of the heart, traumatic heart disease, intracranial 
haemorrhage, hyperkalemia, pericarditis, early repolarisation, and cardiac 
sarcoidosis. The presence or absence of Q waves does not reliably 
distinguish between transmural and non transmural infarction. Q waves 
denote abnormal electrical activity. Data tell that MI without ST segment 
elevations can occur more commonly in older patients and in patients 
with history of prior myocardial infarction.  
Patients with Q waves and ST segment changes diagnostic of 
STEMI in one territory often have ST segment depression in other 
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territories. It implies poor prognosis and is caused by ischemia in a 
territory other than the area of infarction. It is termed as ‘ischemia at a 
distance’.  
ECG changes in right ventricular infarction:    
Right ventricular infarction usually presents with ST segment 
elevation in the right precordial leads (V1, V3R to V6R). It is a relatively 
sensitive and specific sign.  Occasionally, right ventricular infarction 
presents with ST elevation in leads V2 and lead V3. A concurrent inferior 
wall injury suppresses this anterior ST segment elevation. Also a right 
ventricular injury reduces the anterior ST segment depression which is 
observed in a case of inferior wall myocardial infarction.  
Echocardiography:   
The portability of echocardiogram makes it an ideal equipment for 
assessing patients with myocardial infarction. [71] in patients with chest 
pain but with nondiagnostic ECG, echocardiogram helps in diagnosing by 
identifying the  areas of  disordered contraction which is consistent with 
ischemia. Echocardiogram also helps in evaluating the patients with 
chestpain and suspected aortic dissection. Presence of intimal flap is 
consistent with aortic dissection and which is a major contraindication for 
thrombolysis. The LV function estimated from echocardiogram correlates 
well with the measurements from angiograms and is helpful in the 
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prognosis after MI. the early use of echocardiogram can help identify 
potentially viable but stunned myocardium, residual provocable ischemia, 
patients at risk for development of congestive cardiac failure and 
mechanical complications of MI. Although transthoracic echo is 
sufficient, trans-esophageal ECHO is used in those with poor ECHO 
window. Doppler technique helps in assessing the blood flow in the 
cardiac chambers and across the cardiac valves. When used in 
conjunction with echocardiogram, it can help detect and assess the 
severity of mitral or tricuspid regurgitation. It can help identifying the site 
of ventricular septal rupture, quantification of shunt flow across and 
assessment of cardiac tamponade.  
Computed tomography:  
It helps in assessing the cavity dimensions and wall thickness, 
detects left ventricular aneurysm, and in patients with STEMI, identifies 
intracardiac thrombi. Although a less convenient technique, computed 
tomography is more sensitive than echocardiogram in the detection of 
thrombus.  
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Cardiac Magnetic resonance imaging:  
Cardiac Magnetic Resonance (CMR) imaging permits early 
recognition of MI and gives an assessment of the severity of ischemic 
insult. It can assess the perfusion of infarcted and non infracted tissue as 
well as the reperfused myocardium. It identifies myocardial edema, 
fibrosis, wall thinning, fibrosis, hypertrophy, assess ventricular chamber 
size and segmental wall motion and identifies the transition between 
ischemia and infarction, [72]main disadvantage is the need to transport 
the patient in acute phase which is not feasible. 
Contrast enhanced CMR can detect myocardial infarction 
accurately. The transmural extent of late gadolinium enhancement in 
regions of dysfunctional myocardium  accurately predicts the likelihood 
of contractile recovery after successful restoration of coronary flow from 
mechanical revascularization.[90]  Apart from detecting infarction, this 
imaging technique can characterize the presence and size of 
microvascular obstruction from infarction.  
Nuclear imaging:   
Radionucleotide angiography, perfusion imaging, infarct- avid 
scintigraphy, and positron emission tomography are being used to 
evaluate patients with STEMI. [73] Nuclear imaging techniques are used 
in detecting MI, assessing infarct size, collateral flow, and jeopardized 
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myocardium and thus helps in establish prognosis. They are used in 
situations where the triad of clinical history, electrocardiography and 
serum markers are unreliable or unavailable. 
Estimation of infarct size: 
The quantity of the myocardium infracted has important prognostic 
implications.  
The sum of ST segment elevations measured from multiple 
precordial leads correlates with the extent of myocardial injury in patients 
with anterior wall myocardial infarction. [74] Studies also show 
relationship between the number of leads showing ST-segment elevation 
and mortality rate. 
Serial measurement of proteins released by the dead myocardium 
help in determining the infarct size. Peak CK or CK-MB values can 
provide an approximate estimate of infarct size. Reperfusion can washout 
these enzymes resulting in early peaking thus limiting its usefulness in 
estimating infarct size. Measurement of cardiac specific Troponin levels, 
even in cases of successful reperfusion  may provide a reliable estimate of 
infarct size, because such late Troponin measurements reflect delayed 
release from from the myofilament bound  pool in injured myocytes.[75]  
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Newer imaging techniques:   
Contrast enhanced CMR can aid in assessment of infarct size.  It 
also demonstrates regional heterogenecity of infarction patterns in 
patients with persistently occluded arteries, compared with those with 
successfully reperfused vessels.[76] 
MANAGEMENT: 
Prehospital care: 
The prehospital care is a crucial element in the survival of patients 
with suspected STEMI. Most of the deaths occur due to ventricular 
fibrillation and and usually within one hour. Hence transporting the 
patient to a hospital with facilities is of prime importance. Major cause of 
delay from the onset of symptoms to reperfusion include  
        1] Delay of the patient in recognising the seriousness of the problem 
        2] Prehospital treatment and transport of the patient. 
        3] The time for diagnostic measures and initiation of treatment in the 
    hospital (door-to-needle time or door-to- balloon time) 
        4] Time from initiation of treatment and restoration of low. 
Proper patient education is necessary in preventing the time delay 
of the patient in seeking medical attention. Older age, female sex, black 
race, low socioeconomic status, history of angina, diabetes or both, 
consulting a spouse or a relative are factors associated with a delay in 
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seeking medical advice.[77,78] Patients should be advised to seek 
medical advice if symptoms such as chest discomfort, dyspnea. Patient 
should be instructed in the proper use of sublingual nitroglycerine and to 
call emergency services if the cardiac type of pain persists for more than 
five minutes. [79] 
Prehospital fibrinolysis:   
Early treatment of STEMI provides greater benefit. A meta 
analysis of all the available trials showed a 17 percent reduction I 
mortality. The CAPTIM trial which compared prehospital fibrinolysis 
with the primary PCI showed a lesser mortality with the former if the 
patients are being treated within two hours of onset of symptoms. 
Prehospital fibrinolysis is reasonable bin settings where the physicians 
are present in the ambulance or there is fully trained paramedics who are 
fully capable of obtaining and transmitting the 12- lead ECG and initiate 
prehospital thrombolysis.[80,81] 
Because the 12-lead ECG is at the centre of the decision pathway 
for initiation of reperfusion therapy, it should be obtained promptly (≤10 
minutes) in patients presenting with ischemic discomfort.  The decision 
whether to thrombolyse the patient or to do primary intervention depends 
on the availability of skilled personnel, time taken from onset of pain to 
intervention, presence or absence of facilities in the treating hospital. 
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Thrombolysis is preferred if the presentation is less than 3 hours, the 
catheterization facilities are not available, there is difficulty in vascular 
access, there is possible delay in transporting the patient to an equipped 
center.  
Contraindications for thrombolysis: 
1] Prior intra cranial haemorrhage 
2] Known structural cerebral vascular lesions like arteriovenous 
malformations. 
3] Known intracranial neoplasm 
4] Ischemic stroke within 3 months except acute ischemic 
stroke within 3 hour. 
5] Suspected aortic dissection 
6] Any active bleeding except those during menses. 
7] Any closed head or facial trauma within 3 months 
Other measures:  
Aspirin: Aspirin forms part of the initial management of patients 
with suspected STEMI. Because low dose may take several days to 
achieve full antiplatelet effect, at least 162 to 325mg should administered 
in emergency department. The patient is asked to chew the tablet which 
promotes faster absorption than through the gastric route. 
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Control of Cardiac Pain : Control of cardiac pain is very 
important in treating patients with STEMI. Control of pain uses a 
combination of nitrates, analgesics (e.g., morphine), oxygen, beta 
blockers( in selected patients)[82] since the pain in STEMI is due to 
ongoing ischemia, interventions that improve the oxygen supply- demand 
relationship can alleviate the cause of pain.   
  
Analgesics:  Morphine remains the drug of choice in treatment of 
pain in patients with myocardial infarction unless there is a well 
documented history of morphine hypersensitivity.  A dose of 4 to 8 mg 
should be given intravenously and should be repeated at intervals of 5 to 
15 minutes until the pain is relieved or there is evidence of toxicity like 
hypotension, depression of respiration or severe vomiting. Morphine 
reduces the anxiety and decreases the activity of autonomic nervous 
system. It causes peripheral arterial and venous dilatation in cases with 
pulmonary edema. It slows the heart rate secondary to withdrawl of 
sympathetic tone and augmentation of vagal tone.    
     Hypotension following the administration of nitroglycerin and 
morphine can be minimized by maintaining the patient in a supine 
position and elevating the lower extremities if systolic arterial pressure 
declines below 100 mm Hg. Use of atropine can counteract the 
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vagomimetic action of morphine. Respiratory depression is an unusual 
complication of morphine in the presence of severe pain or pulmonary 
edema. Respiratory depression can be treated with naloxone 0.1 to 0.2 mg 
initially and repeated 15 minutes later if necessary. 
Nitrates: By acting as coronary vasodilators and by decreasing 
ventricular preload, sublingual nitrates form one of the important drugs in 
treating most patients with ACS. Sublingual nitroglycerine is 
contraindicated in patients with inferior wall myocardial infarction or in 
those with systolic blood pressure less than 90 mmHg.[83] . The 
hypotension and bradycardia caused by nitrates can be reversed by 
intravenous atropine.  
Beta blockers:  they relieve the ischemic pain, reduce the need for 
analgesics, and reduce the infarct size and life threatening arrhythmias. It 
is better to avoid beta blockers in patients with killip class II or higher, in 
those with bradycardia, those with AV blocks. Metoprolol is given as 
three 5 mg intravenous doses. 
Oxygen:  Hypoxemia in patients with STEMI results from 
ventilation perfusion abnormalities as a result of left ventricular failure. 
Pneumonia and intrinsic pulmonary diseases are additional causes. It is 
common practice to use oxygen for 12-48 hours after admission. But 
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studies say that oxygen is required in those with saturation less than 90%. 
In others, oxygen therapy is not useful infact it can even lower the cardiac 
output by increasing the systemic vascular resistance and arterial 
pressure. Usually, 2 to 4 litres of 100 percent oxygen is necessary for 
about 6 to 12 hours. If patient not responds to this mode, flow rate has to 
be increased or in cases of pulmonary edema, endotracheal intubation 
may be necessary. 
 
Reduction of infarct size: Bed rest both physical and emotional is 
needed and this is achieved by using mild sedation and treating in a quiet 
atmosphere. Betablockers reduce the infarct size and they should be used 
unless otherwise contraindicated. Marked sinus bradycardia and 
hypotension should be adequately treated. All forms of tachyarrhythmia 
should be treated as they increase myocardial oxygen demands.[84] 
Congestive cardiac failure should be treated promptly with inhibitors of 
RAAS unless contraindications are present. Oxygen enriched air should 
be used. Blood pressure should be maintained within a optimal range.  
Severe anemia if present should be treated with packed cell transfusions. 
 
REPERFUSION THERAPY: 
Fibrinolysis recanalizes the occluded artery in a case of STEMI 
thereby causing restoration of blood flow resulting in decrease in infarct 
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size and improvement of myocardial function.[85,86]. Nowadays PCI are 
done in large numbers to treat such patients 
 
Several methods are used in evaluating the adequacy of myocardial 
perfusion. Electrocardiographic changes in the form of ST segment 
resolution can help in predicting the outcomes in a case of 
STEMI.[87,88] persistence of ST segment changes in a patient after 
successful PCI denotes worse prognosis in the form of increased left 
ventricular dysfunction and mortality. This can be due to microvascular 
damage in the infarct zone. Thus the 12- lead ECG is a marker which 
reflects the myocyte integrity and reflects the inadequacy of myocardial 
perfusion[89]. Also the cardiac biomarkers provide important information 
regarding the prognosis in STEMI patients[90].  
 
Fibrinolysis: 
 
Early fibrinolysis improves the survival in patients with 
STEMI.[84] It is beneficial if it is administered as early as possible. Best 
results are obtained if it is given within 2 hours of the onset of 
symptoms.[91]   
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(Fig8: showing effect of early thrombolysis on the patient’s lives) 
 
A number of agents are used in fibrinolysis like streptokinase, and 
tissue plasminogen activators. The choice of the drug to be used depends 
on the duration of onset, age, comorbidities. In patients presenting within 
4 hours of symptoms, the important factor is the speed with which the 
occluded vessel is reperfused. This can be achieved by high intensity 
fibrinolytic such as t-PA. But in those whose risk of death is low, and in 
those where the risk of intracranial bleed is high, streptokinase and t-PA 
are equivalent choices. For those who present between 4 and 12 hours 
after the onset of chest pain, the speed of reperfusion is of lesser 
importance and thus streptokinase and t-PA are of equal options. 
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PCI:  
When performed rapidly and in a experienced center, primary PCI 
is superior to reperfusion therapy.[92] Controversy arises regarding the 
best approach when immediate PCI can’t be done and delay occurs. The 
outcome of the PCI varies with the experience of the operator and the 
center. Therefore, the optimal therapy in treating the patient depends on 
the available resources and the type of patients. When a experienced team 
is available and door to balloon time can be achieved <90 minutes, PCI is 
the ideal method of reperfusion. Also in old patients, who have increased 
risk of haemorrhage from fibrinolysis, PCI is the better option. The 
thrombi mature over time and become resistant to thrombolysis. In such 
conditions (ie> 3 hrs), PCI is the best option which can open up the 
occluded vessel. When the diagnosis is in doubt, PCI is the best 
procedure. 
Surgery: 
        Surgery in acute MI performed if the chest pain persist inspite of 
thrombolysis or primary PCI; presence of high risk lesions like left main 
stenosis; ventricular septal rupture or severe mitral regurgitation 
complicating MI. 
 63 
Anticoagulant and antiplatelet therapy: 
The aim of administering anticoagulants in STEMI patients are as 
follows 
1. Prevention of deep venous thrombosis. 
2. Prevention of pulmonary embolism 
3. Preventing thrombus formation in the ventricle. 
4. Preventing emboli to brain. 
5. Establishment and maintenance of infarct related artery 
patency 
Anticoagulants should be continued for at least 48 hours after 
thrombolysis and maintained to an aPTT of 1.5 to 3 times the normal. 
Unfractioned Heparin(UFH) was used initially. Disadvantages in 
using UFH are that it depends on anti thrombin III for inhibiting thrombin 
activity, its sensitivity to platelet factor 4, inability to inhibit clot bound 
thrombin and interpatient variability. In contrast, the Low Molecular 
Weight Heparins(LMWH)  are stable, have reliable anticoagulant effect 
and have high bioavailability. 
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Antiplatelet therapy:   
The common antiplatelets used are aspirin, clopidogrel, ticlopidine, 
prasugrel , ticagrelor. Disruption of coronary artery plaque is major event 
in the evolution of myocardial infarction. [93] Platelets are released in 
response to fibrinolysis and platelet rich thrombi are more resistant to 
fibrinolysis than fibrin and erythrocyte rich thrombi. Thus the use of 
antiplatelet drug is very important in a case of STEMI. The most 
extensively used drug is aspirin. It is used in a loading dose of 162 to 325 
mg followed by a continuation dose of 75 to 162 mg. Clopidogrel or 
ticlopidine are used if patient does not tolerate aspirin. Antilipidemics, 
adequate bed rest, stool softeners, appropriate management of 
arrhythmias and other complications, use of RAAS blockers and 
aldosterone blockers are important in managing patients with STEMI. 
Emerging therapy: 
Studies are going on for a better improvement of the health of 
STEMI patients. Anti Neutrophilic drugs, ET-1r antagonists, TXA2r 
antagonists, antiplatelets are being studied for preventing reperfusion 
related injury, thrombus aspiration techniques help in removing the 
occluded thrombus, and methods to reduce the oxygen consumption are 
being studied. The burgeoning field of cardiac regenerative medicine is 
now focusing on several approaches using endogenous and exogenous 
sources of cells that may give rise to myocytes.  
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AIM OF THE STUDY 
To identify left ventricular ejection fraction of less than or equal to 
40 percent by quantitatie Troponin T measurement after first episode of 
ST elevation Myocardial Infarction.  
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MATERIALS AND METHODS 
This study was conducted in Government Royapettah hospital in 
the Department of Medicine between July and December 2012. Fifty 
consecutive patients with first attack of ST elevation of myocardial 
infarction were selected and observed. Myocardial infarction was 
diagnosed by the following criteria 
1. Typical cardiac chest pain 
2. Presence of ST segment elevation of more than 2mm in 
chest leads or more than 1mm in 2 contiguous limb leads or 
presence of Q waves in two consecutive leads. 
3. Elevated Creatinine Kinase levels more than twice from the 
baseline. 
Exclusion criteria: 
1. Patients with previous history of myocardial infarction 
2. Severe renal impairment 
3. History of cardiac failure 
Troponin T levels are measured 12 to 48 hours after admission so 
as to obtain its peak value. All patients received standard therapy like anti 
platelets, anti lipidemics, anti coagulation with heparin, fibrinolytics (if 
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the criteria for administering these drugs are met) and supportive care. 
Two dimensional Echocardiography was done 3 to 4 weeks later and 
ejection fraction was measured.  
The relationship between left ventricular ejection fraction and 
troponinT concentration was studied using spearman’s correlation 
coefficient. The relation between Troponin T concentration and ejection 
fraction was examined by constructing a receiver operator characteristic 
(ROC) curve. Patients were initially categorised in to two groups; those 
with ejection fraction of less than 40 percent and those with ejection 
fraction more than 40 percent. Then sensitivity and specificity of 
Troponin was determined. Sensitivity was plotted against 1- specificity 
and ROC curve was produced. The test is better if the curve is near the 
top left corner. The point of inflection of the ROC curve allows selection 
of the best trade off between sensitivity and specificity.  
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RESULTS 
Total people under the study were 50. Of the total 50 people who 
were involved in the study, 46 were male (90%) and 4 were females 
(10%).  
 
                                                    Descriptive Statistics 
 
N Minimum Maximum Mean 
Std. 
Deviation 
age 50 28 80 54.34 12.356 
Valid N 
(listwise) 
50 
    
 
The mean age of the study group is 54.34 years (max 28 yrs and 
min 80 yrs) with a standard deviation of 12.356 
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Most of the patients were in the age group of 41 to 50 yrs(30 
percent) followed by age group between 61 to 70 yrs(24%). Incidence of 
myocardial infarction in females rises after 50 yrs whereas in males it 
peaks in the age group of 40 to 50 yrs.  
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Considering the occupation, the incidence is more common among 
the autodrivers (44 percent) followed by others 
 
Type of myocardial infarction also varies with ages. The most 
common type of myocardial infarction was acute anterior wall infarction 
which is present in 22 patients (44%). Anterior wall MI was common 
among younger age groups whereas in the older age group, inferior wall 
MI predominated. Of the 50 patients, 31 were hypertensive (62%), 29 of 
them (58%) were diabetic. Hypercholesterolemia was present in 22 
patients (44%), hypertriglyceridemia in 16 (32%). There were 33 smokers 
(66%) and 35 alcoholics (70%). 
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Descriptive Statistics 
 
N 
Minimu
m 
Maximu
m Mean 
Std. 
Deviation 
age 50 28 80 54.34 12.356 
sugar 50 73 347 145.90 45.903 
urea 50 22 84 42.16 17.171 
creatinine 50 .3000 2.2000 1.144000 .3855343 
cholesterol 50 127 378 207.90 50.477 
TGL 50 73 329 182.66 66.199 
ejn frction 50 30 65 43.28 8.636 
SHT( yrs) 50 0 20 4.66 4.830 
SBP 50 100 176 144.20 19.518 
DBP 50 30 110 88.04 15.761 
diabetes(yrs) 50 0 15 4.18 4.543 
trop T levels 50 .2340 10.0000 5.644920 3.3080123 
Valid N 
(listwise) 
50 
    
 
The mean cholesterol value is 207.90mg/dl, blood sugar level 
145.90 mg/dl, Triglyceride- 182.66mg/dl, ejection fraction- 43.28, mean 
systolic blood pressure is 144.20mm Hg( minimum 100 mmHg; 
maximum 176 mm Hg), mean diastolic blood pressure is 88.04mmHg( 
min-30 mm Hg and max-110 mm Hg). The mean Troponin level was 
5.644 with the lowest value being 0.234 and the greatest value being10. 
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Ejection fraction interval 
 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 1.00 29 58.0 58.0 58.0 
2.00 21 42.0 42.0 100.0 
Total 50 100.0 100.0  
 
Of the patients admitted, 29 of them had ejection fraction less than 
40 percent(58%) and 21 of them had ejection fraction more than 40 
percent.(42%) 
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qSymmetric Measures 
 
Value 
Asymp. Std. 
Error
a
 
Approx. 
T
b
 
Approx. 
Sig. 
Interval by 
Interval 
Pearson's R -.860 .027 -11.656 .000
c
 
Ordinal by 
Ordinal 
Spearman 
Correlation 
-.874 .029 -12.473 .000
c
 
N of Valid Cases 50    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
c. Based on normal approximation. 
 
X axis- ejection fraction(%)  
Y axis- no. of patients              
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There was a strong negative correlation between the left ventricular 
ejection fraction and Troponin T levels. Spearman’s rank correlation 
coefficient was -0.874 with p values <0.0001 
 
Analysis of ROC curve produced an area under the curve of 0.970 
(95% of confidence interval  0.000 to 1.000. Troponin T value more than 
2.9 predicted a LV ejection fraction of <40 % with a high sensitivity and 
specificity.   
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Area Under the Curve 
Test Result Variable(s):trop T levels 
Area Std. Error
a
 
Asymptotic 
Sig.
b
 
Asymptotic 95% Confidence 
Interval 
Lower 
Bound Upper Bound 
.970 .019 .000 .000 1.000 
  
 The test result variable(s): trop T levels has at least one tie between 
the positive actual state group and the negative actual state group. 
Statistics may be biased. 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5 
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DISCUSSION 
Troponin is a highly reliable marker in the detection of cardiac 
injury. Its use is increasing in modern era in the diagnosis of acute 
myocardial infarction. Studies tell that the cardiac troponin T measured 
correlates well with the infarct size and thus indirectly denote left 
ventricular ejection fraction.  
This study shows a strong negative correlation between troponin T 
measured 12 to 48 hours post MI and the ejection fraction measured by 
2D echocardiography. Relation between cTroponin T and ejection 
fraction by ROC curve show that troponin T concentration of >2.9 is 
highly sensitive and specific indicator of depressed LV function 
(LVEF<40 percent) after a first attack of STEMI.  
Troponin T forms one of the important markers in the diagnosis of 
myocardial infarction. It has many advantages in assessing the LV 
ejection fraction compared to other markers. After an episode of 
myocardial infarction, Trop T level raises above the baseline and peaks at 
about 12 hours. However, the plateau phase lasts for about 48 hours. This 
peak value represents the total amount of myocytes injured. After 12 to 
48 hours, the peak value will be missed. Since there is a large time 
window, repeated sampling is not needed for quantifying the peak value. 
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Other cardiac injury markers like creatinine kinase and myoglobin are not 
preferred as they need multiple sampling to determine their peak levels.  
A study done by ACR Rao et al showed similar results. They 
selected 50 consecutive STEMI patients with a first episode of 
myocardial infarction and did Troponin level and ejection fraction by 
angiography. Patients with prior history of myocardial infarction were 
excluded as they may show falsely low ejection fraction. This study 
showed a strong negative correlation between and LV ejection fraction. 
Spearman’s corellation coefficient was -0.72( 95 percent confidence 
interval) with p<0,0001. Analysis by ROC produced an area under the 
curve of 0.9773 (95 percent confidence interval 0.9409 1.0131) which 
was similar to our study. In their study, Trop T more than 2.8μg/L 
predicted an LVEF of less than 40 percent which was slightly higher in 
our study.  
Another study done by Deepak Somani et al in northern India 
found a strong negative correlation between Troponin I concentration and 
left ventricular ejection fraction. The pearson’s correlation coefficient 
was 0.69, which was statistically significant (<0.0001) 
Regarding the risk factors, studies tell that the incidence of 
myocardial infarction increases with age. The incidence of myocardial 
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infarction rises after the age of 45 in males and more than 55 years in 
females. Our study too showed similar results with more number of cases 
in the age group of > 45 years in males and in females it was more 
prevalent in the post menopausal age group. 
Of the 50 people, 66 percent were smokers. Smoking has got 
influence on blood pressure and sympathetic tone. It also causes reduced 
myocardial oxygen supply. Long duration of smoking increases the 
oxidation of Low density lipoprotein cholesterol and impairs endothelium 
dependent coronary artery vasodilation. It also promotes spontaneous 
platelet aggregation. This is responsible for the increased incidence of MI 
among smokers. Critchley JA et al in an article published in JAMA 2003, 
concluded that smoking cessation as an effective way to reduce CAD 
mortality by 36 percent as compared to those who continue to smoke. 
In a study done by Booth GK et al (lancet 2006;368:29), insulin 
resistance and  diabetes are one of the leading risk factors for Coronary 
Artery Disease. The presence of diabetes conferred an equivalent risk to 
aging 15 years, an impact higher than that of smoking. In our study 58 
percent of the people were diabetics and smokers outnumbered diabetics. 
This is high time for emergency steps to be taken to stop smoking in our 
community as the smokers are on the steep rise.  
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Although it has been told that mild alcohol consumption has been 
cardio protective, heavy drinking has got adverse effects on the heart. 
Although most of the people in our study had multiple risk factors, almost 
70 percent of the people were alcoholics who consume in large amounts 
and for long duration. In a study published by I Byik et al in journal of 
international medical research in 2007, they found increased coronary 
disease incidence in those who consumed alcohol in large quantities. This 
is probably due to reduction in prostaglandin F 1α and cyclic GMP 
leading on to coronary vasospasm.    
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LIMITATION OF THE STUDY 
1] This study is done in small number of patients. Study in a 
large group of people is further needed. 
2] The left ventricular ejection fraction is measured by 2D 
echocardiography and not by angiographic methods which is 
a gold standard. LVEF measured by 2D echo shows lower 
value than that measured angiographically. 
3] The ejection fraction measured by 2D echocardiography is 
prone for inter observer variations and thus the ejection 
fraction measured may not reflect the true values. 
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CONCLUSION 
Troponin T show a strong negative correlation with left ventricular 
ejection after a first episode of myocardial infarction. Its measurement is 
a quick, cheap, sensitive and highly specific method in identifying cardiac 
injury and to determine low ejection fraction <40 percent which is 
associated with complications. Thus its measurement helps in identifying 
patients who are at higher risk from MI and guide in starting the drugs 
like ACE inhibitors earlier  which provide survival benefit. Multiple 
measurements are not necessary in determining its peak value as it has 
got a large time window unlike the other cardiac biomarkers which 
necessitate multiple measurements to determine their peak level. 
DISCLOSURE:  
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CLINICAL EXAMINATION: 
      CARDIO VASCULAR SYSTEM: 
      RESPIRATORY SYSTEM: 
      ABDOMEN: 
      CNS: 
BODY MASS INDEX: 
INVESTIGATIONS: 
      BLOOD SUGAR: 
      UREA: 
      CREATININE: 
      LIPID PROFILE: 
      CPK: 
      TROPONIN T: 
      ECG: 
      ECHOCARDIOGRAM (1): 
 
 
 
      ECHOCARDIOGRAM (2): 
ABBREVATIONS 
 
CK-MB – Creatine Kinase- (Muscle Brain subunit) 
LDL – Low Density Lipoprotein 
HDL – High Density Lipoprotein 
BMI – Body Mass Index 
TGL – Triglycerides 
SBP – Systolic Blood Pressure 
DBP – Diastolic Blood Pressure 
LV – Left Ventricle 
EDHF – Endothelial Dependent Relaxing Factor 
cGMP – cyclic Guanosine Mono Phosphate. 
ET – endothelin 
GTP – Guanosine Tri Phosphate 
RV – Right Ventricle 
ATP – Adenosine Tri Phosphate 
NO – Nitric Oxide 
ACS – Acute Coronary Syndrome 
ECG – Electro cardiogram 
ACC/AHA – American Heart Association 
COPD – Chronic Obstructive Pulmonary Disease 
CCF – Congestive Cardiac Failure 
MDCT – Multi Detector Computerized Tomography 
MRI – Magnetic Resonance Imaging 
PCI – Primary Coronary Intervention 
CABG – Coronary Artery Bypass Grafting 
STEMI – ST segment Elevation Myocardial Infarction 
t-PA – Tissue Plasminogen Activator 
PAI – Plasminogen Activator Inhibitor 
DNA – Deoxy Ribo Nucleic Acid 
RVMI – Right Ventricular Myocardial Infarction 
NSAID – Non Steroidal Anti inflammatory Drugs 
RAAS – Renin Angiotensin Aldosterone  System 
SGOT – Serum Glutamate Oxaloacetate Transferase. 
ICD – Iso Citrate Dehydrogense 
CMR – Cardiac Magnetic Resonance 
AV – Atrio Ventricular 
UFH – Unfractioned Heparin 
LMWH – Low Molecular Weight Heparin 
TXA2 – Thromboxane A2 
ROC curve  – Receiver Operator Characteristic curve. 
2D – Two Dimensional 
ACE – Angiotensin Converting Enzyme. 
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1 babu 64 m 107439 cooly 112 24 1 168 159 IMMI 32 1 4 154 100 8 1 10 10 20 1 
2 ismail 76 m 100920 shop keeper 146 83 0.8 273 153 IWMI 36 1 12 140 90 8 1 8 10 10 1 
3 jayaraman 38 m 113210 auto driver 123 84 1 320 157 ALMI 38 0 0 140 90 5 1 0 10 0 0 
4 parvathy 65 f 107692 housewife 180 32 1.1 278 297 IWMI 30 1 3 160 100 15 1 0 10 0 0 
5 vasu 48 m 102995 autodriver 140 26 0.7 190 219 IPMI 37 1 5 158 30 5 1 7 10 6 1 
6 mahaboo jan 65 f 100397 housewife 156 58 1.5 167 208 AWMI 30 1 8 168 100 10 1 0 10 0 0 
7 paramasivan 55 m 102022 autodriver 140 39 1.4 247 188 IWMI 38 0 0 138 70 4 1 0 10 0 0 
8 sriramulu 70 m 999665 nil 147 40 1.6 216 260 HLMI 40 1 5 150 90 15 1 0 9.56 30 1 
9 chitravel 62 m 100490 daily wage 130 61 1 210 159 AWMI 38 1 6 156 90 15 1 7 9.45 10 1 
10 
velimaran 66 m 101764 watchman 180 48 0.8 169 162 
EAW
MI 38 0 0 130 80 5 1 0 9.4 0 0 
11 pazhani 43 m 999570 autodriver 198 24 0.9 223 119 AWMI 34 1 3 166 108 0 0 20 9.08 25 1 
12 munusamy 60 m 112530 watchman 132 72 1.1 127 165 ALMI 39 1 10 168 90 0 0 10 9.07 10 1 
13 ravi 50 m 101221 autodriver 150 58 1.5 150 80 IWMI 38 0 0 136 80 3 1 20 8.46 20 1 
14 jayaraman 40 m 102598 labourer 160 44 1.1 284 218 AWMI 35 1 3 176 110 5 1 0 8.4 0 0 
15 deenadayala
n 64 64 m 998387 watchman 98 30 1.1 265 267 ASMI 40 1 20 172 90 0 0 7 8.36 15 1 
16 sampath 66 m 101484 watchman 120 38 1.6 190 75 AWMI 39 1 8 158 96 0 0 0 7.9 0 0 
17 
saravanan 46 m 102890 labourer 136 25 0.8 184 182 
EAW
MI 37 1 8 130 70 6 1 0 7.9 5 1 
18 natarajan 52 m 101223 vendor 150 30 1 301 169 AWMI 36 0 0 140 80 0 0 4 7.9 6 1 
19 shafee 72 m 102331 shop keeper 86 42 1.7 378 137 IWMI 40 1 14 170 100 0 0 6 7.7 35 1 
20 kathirvel 50 m 101815 autodriver 238 58 1.8 198 189 ASMI 37 0 0 120 70 0 0 7 7.4 0 0 
21 sekar 67 m 101975 mason 156 78 0.9 217 178 IPMI 40 1 9 160 90 7 1 8 6.9 0 0 
22 ravi 53 m 999570 autodriver 73 60 1.5 140 73 AWMI 40 0 0 100 60 0 0 30 6.89 30 1 
23 
sekar 50 m 102658 autodriver 165 28 1 213 274 
EAW
MI 39 1 8 162 80 3 1 8 6.8 10 1 
24 saminathan 62 m 100486 autodriver 126 55 0.3 196 168 AWMI 41 1 10 170 110 0 0 0 6.5 25 1 
25 selvaraj 74 m 998590 watchman 110 48 1.4 200 288 IPLMI 38 0 0 120 70 8 1 7 5.86 30 1 
26 selvaraj 46 m 106840 auto driver 162 24 0.8 140 135 EAW
MI 
40 1 6 146 100 0 0 20 5.77 5 1 
27 gnanavel 36 m 110868 autodriver 113 28 0.8 180 268 AWMI 41 0 0 140 80 0 0 5 5.6 0 0 
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28 chelladurai 37 m 999739 clerk 80 24 0.8 229 329 AWMI 42 0 0 120 80 5 1 8 5.2 7 1 
29 suseela 80 f 102008 housewife 146 40 1.8 249 174 IWMI 39 1 10 166 90 5 1 0 5.2 0 0 
30 pandiyan 35 m 107036 autodriver 136 26 0.6 186 140 ALMI 41 0 0 120 82 0 0 10 5.08 10 1 
31 sankaran 42 m 112032 autodriver 154 63 1.5 298 178 ALMI 38 1 5 150 100 4 1 10 4.65 10 1 
32 usha 55 f 111245 housewife 195 24 1.9 185 140 AWMI 40 0 0 100 70 0 0 0 4.56 0 0 
33 jabbar 50 m 110835 business 156 30 0.9 200 150 AWMI 42 1 4 166 110 6 1 0 4.3 0 0 
34 saminathan 62 m 100774 autodrver 87 53 1.3 216 87 IWMI 54 0 0 110 74 0 0 3 2.78 30 1 
35 mathiyazhga
n 44 m 110843 autodriver 130 22 0.8 180 180 AWMI 40 1 6 130 90 0 0 10 2.6 9 1 
36 natarajan 56 m 112120 autodriver 136 40 1.2 189 264 IWMI 56 0 0 110 80 0 0 0 2.58 0 0 
37 sabir 43 m 102186 nil 112 28 1.2 219 163 ASMI 57 0 0 130 60 0 0 5 2.3 0 0 
38 subramani 80 m 100478 watchman 167 62 1.2 173 218 IPLMI 49 1 10 120 80 15 1 4 2.1 6 1 
39 dhavamani 53 m 101249 autodriver 129 49 0.7 160 155 IWMI 58 1 10 154 100 10 1 30 2.08 0 0 
40 syed abdul 
razak 62 m 998940 nil 80 25 1 171 316 HLMI 52 0 0 134 74 5 1 0 2.06 6 1 
41 nagappan 60 m 113320 autodriver 176 70 2.2 215 118 IWMI 45 1 8 160 90 10 1 12 2 10 1 
42 
Babu 42 m 101307 office clerk 120 30 1.4 159 158 
EAW
MI 48 0 0 150 96 0 0 10 2 10 1 
43 Rajkumar 55 m 101292 autodriver 254 48 1 246 128 IWMI 56 1 7 160 110 5 1 8 1.9 8 1 
44 kannan 60 m 100965 watchman 156 29 1 152 114 AWMI 56 1 4 130 96 5 1 30 1.8 30 1 
45 mani 50 m 100496 mason 164 49 1.7 183 226 AWMI 52 1 15 150 100 0 0 8 1.8 8 1 
46 gopinath 45 m 107023 security 135 36 1 220 106 IPWMI 65 0 0 130 90 6 1 5 0.96 10 1 
47 sivakumar 38 m 106967 autodriver 134 32 0.7 187 150 AWMI 60 1 2 154 110 0 0 6 0.65 7 1 
48 kuppan 45 m 999747 autodriver 347 22 0.8 210 324 AWMI 62 1 6 148 106 5 1 9 0.256 25 1 
49 venkatesan 55 m 112118 cook 145 34 1.3 176 250 ASMI 50 1 4 150 90 6 1 2 0.256 0 0 
50 jayakumar 28 m 998351 autodriver 129 35 1 168 118 AWMI 51 0 0 140 100 0 0 6 0.234 20 1 
 
 
 
